We’re thrilled to partner with INDICAL and combine their twenty years of experience preventing and monitoring animal diseases with our full suite of end-to-end mobile molecular solutions in an effort to advance One Health initiatives.
PHILADELPHIA and LEIPZIG, Germany (PRWEB) May 20, 2019
Biomeme, Inc. and INDICAL BIOSCIENCE announced on Wednesday that they have entered into an exclusive global licensing and research agreement in a joint effort to improve animal health globally. Biomeme has been primarily developing advanced mobile PCR detection technology for biothreat and environmental surveillance over the last six years. This partnership reinforces their role in these respective fields while further extending their end-to-end mobile PCR technology into the animal health and animal protein production spaces.
INDICAL, formerly QIAGEN’s veterinary diagnostic business, and a leader in advanced testing systems for safe, reliable identification of pathogens in poultry and livestock, will immediately adapt Biomeme’s molecular point-of-need testing technology for its veterinary and animal protein production customers. “With this technology, we introduce a new, yet easy-to-use solution to veterinarians, clinics, government agencies, and the food industry that solves time-sensitive and location-sensitive problems where results need to be in real-time and actionable without a lab or its infrastructure,” said Dr. Fredrik Ullman, CEO of INDICAL. “Biomeme’s connected devices, cloud portal, and API technology all uniquely enable the digitalization of farming, empowering our customers with GPS-tagged, real-time test data for monitoring and surveillance.”
“We’re thrilled to partner with INDICAL and combine their twenty years of experience preventing and monitoring animal diseases with our full suite of end-to-end mobile molecular solutions in an effort to advance One Health initiatives,” said Max Perelman, Biomeme’s Co-Founder and Business Lead. “By leveraging their experience with our PCR platform, we expect this collaboration to significantly strengthen our clients’ capabilities in real-time pathogen identification and animal disease surveillance, by bringing the lab to the sample.”
If you’re interested in learning more about how your organization can take advantage of INDICAL and Biomeme’s newly announced partnership, we encourage you to reach out using the contact information on this page.
About Biomeme, Inc.
Biomeme entered into molecular detection over 6 years ago when it created the first iPhone add-on capable of performing real-time PCR. Since its inception, Biomeme has used advanced biology and chemistry, along with world-class hardware and software engineering, to create elegant solutions to complex problems. Headquartered in Philadelphia, USA, Biomeme offers a full suite of end-to-end mobile molecular solutions. Biomeme’s 1-minute sample prep, shelf-stable reagents, hand-held thermocycler, cloud portal, and API perform to the gold standard used by the world’s most advanced central labs but requires no lab equipment or special experience to use.
To find out more about Biomeme, visit http://www.biomeme.com
About INDICAL BIOSCIENCE
At INDICAL, our purpose is to prevent and monitor animal diseases by improving diagnostic
technologies. With two decades of experience, INDICAL (formerly QIAGEN’s veterinary diagnostic business) is a leader in advanced testing systems for the safe, reliable identification of pathogens in poultry and livestock. Headquartered in Leipzig, Germany, INDICAL focuses on complete solutions for molecular and immunological veterinary testing. Its veterinary-specific sample prep technologies, PCR assays and reagents, ELISA kits, and instruments are used by veterinarians, industry, and government agencies worldwide for the identification of animal diseases, such as Avian Influenza and African Swine Fever. With a rapidly expanding presence, INDICAL is currently direct in 17 countries and works with expert Commercial Partners in another 160 countries
To find out more about INDICAL, visit http://www.indical.com